Dermatology NewsMirikizumab beats placebo, secukinumab for psoriasisNovember 2, 2020PsoriasisPsoriatic Arthritis
Dermatology NewsHand eczema: Pan-JAK inhibitor delgocitinib shows dose-dependent response in phase 2b trialNovember 2, 2020Psoriasis
Dermatology NewsData on potential risks of COVID-19 in psoriasis patients limited, but reassuringOctober 23, 2020PsoriasisCOVID-19 UpdatesPsoriatic Arthritis
Dermatology NewsNon-Whites remain sorely underrepresented in phase 3 psoriasis trialsOctober 20, 2020PsoriasisPsoriatic Arthritis
Influenza Vaccination Recommendations During Use of Select Immunosuppressants for PsoriasisOctober 14, 2020Infectious DiseasesPsoriasis
Risk for Deep Fungal Infections During IL-17 and IL-23 Inhibitor Therapy for PsoriasisOctober 13, 2020Infectious DiseasesPsoriasis
Dermatology NewsStudy highlights differences between White and Latino patients with psoriasisOctober 6, 2020PsoriasisPsoriatic Arthritis
Dermatology NewsShingrix effective in older adults with preexisting immune-mediated disordersOctober 5, 2020Psoriatic ArthritisPsoriasis
Dermatology NewsPregnancy studies on psoriasis, PsA medications pick upOctober 1, 2020PsoriasisPsoriatic Arthritis
Active Comparator Trial Designs Used to Promote Development of Innovative New MedicationsSeptember 25, 2020AcneAtopic DermatitisPsoriasisRosaceaHealth Policy
Dermatology NewsStudy results suggest ustekinumab may trigger acute CV events early in treatmentSeptember 18, 2020PsoriasisPsoriatic Arthritis
Dermatology NewsBiologics for psoriasis may also reduce coronary plaqueSeptember 17, 2020PsoriasisPsoriatic Arthritis
Dermatology NewsCOVID-19 outcomes no worse in patients on TNF inhibitors or methotrexateSeptember 16, 2020COVID-19 UpdatesPsoriasisPsoriatic Arthritis
Content Analysis of Psoriasis and Eczema Direct-to-Consumer AdvertisementsSeptember 11, 2020PsoriasisDiversity in Medicine
